ISIS-9069

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameISIS-9069
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProtein kinases inhibitorsPhosphotransferases inhibitors
TargetsPhosphotransferasesProtein kinases
Therapy Area/IndicationsVascular restenosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVascular restenosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A